{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:23:29Z","timestamp":1790637809000,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"48","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,12]],"date-time":"2020-09-12T00:00:00Z","timestamp":1599868800000},"content-version":"vor","delay-in-days":1777,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1074\/jbc.m115.670224","type":"journal-article","created":{"date-parts":[[2015,10,8]],"date-time":"2015-10-08T02:18:43Z","timestamp":1444270723000},"page":"29022-29034","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Distinct Acute Lymphoblastic Leukemia (ALL)-associated Janus Kinase 3 (JAK3) Mutants Exhibit Different Cytokine-Receptor Requirements and JAK Inhibitor Specificities"],"prefix":"10.1016","volume":"290","author":[{"given":"Elisabeth","family":"Losdyck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tekla","family":"Hornakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorraine","family":"Springuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Degryse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Gielen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Cools","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan N.","family":"Constantinescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Flex","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Tartaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Christophe","family":"Renauld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Knoops","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.M115.670224_bib1","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.chembiol.2011.01.012","article-title":"Jak1 has a dominant role over Jak3 in signal transduction through \u03b3c-containing cytokine receptors","volume":"18","author":"Haan","year":"2011","journal-title":"Chem. Biol"},{"key":"10.1074\/jbc.M115.670224_bib2","doi-asserted-by":"crossref","first-page":"47954","DOI":"10.1074\/jbc.M205156200","article-title":"The pseudokinase domain is required for suppression of basal activity of Jak2 and Jak3 tyrosine kinases and for cytokine-inducible activation of signal transduction","volume":"277","author":"Saharinen","year":"2002","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M115.670224_bib3","doi-asserted-by":"crossref","first-page":"37451","DOI":"10.1074\/jbc.M106135200","article-title":"Mapping of a region within the N terminus of Jak1 involved in cytokine receptor interaction","volume":"276","author":"Haan","year":"2001","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M115.670224_bib4","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1006\/bbrc.2001.4824","article-title":"Critical sites for the interaction between IL-2R\u03b3 and JAK3 and the following signaling","volume":"283","author":"Tang","year":"2001","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"10.1074\/jbc.M115.670224_bib5","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1093\/emboj\/18.6.1549","article-title":"Autosomal SCID caused by a point mutation in the N-terminus of Jak3: mapping of the Jak3-receptor interaction domain","volume":"18","author":"Cacalano","year":"1999","journal-title":"EMBO J"},{"key":"10.1074\/jbc.M115.670224_bib6","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1038\/leu.2012.74","article-title":"Newly described activating JAK3 mutations in T-cell acute lymphoblastic leukemia","volume":"26","author":"Bains","year":"2012","journal-title":"Leukemia"},{"key":"10.1074\/jbc.M115.670224_bib7","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ccr.2006.06.002","article-title":"Activating alleles of JAK3 in acute megakaryoblastic leukemia","volume":"10","author":"Walters","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1074\/jbc.M115.670224_bib8","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/ng.2698","article-title":"Exome sequencing identifies secondary mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia","volume":"45","author":"Sakaguchi","year":"2013","journal-title":"Nat. Genet"},{"key":"10.1074\/jbc.M115.670224_bib9","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ejphar.2007.12.024","article-title":"The JAK-3 inhibitor CP-690550 is a potent anti-inflammatory agent in a murine model of pulmonary eosinophilia","volume":"582","author":"Kudlacz","year":"2008","journal-title":"Eur. J. Pharmacol"},{"key":"10.1074\/jbc.M115.670224_bib10","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1046\/j.1600-6143.2003.00281.x","article-title":"The novel JAK-3 inhibitor CP-690550 is a potent immunosuppressive agent in various murine models","volume":"4","author":"Kudlacz","year":"2004","journal-title":"Am. J. Transplant"},{"key":"10.1074\/jbc.M115.670224_bib11","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/nbt1358","article-title":"A quantitative analysis of kinase inhibitor selectivity","volume":"26","author":"Karaman","year":"2008","journal-title":"Nat. Biotechnol"},{"key":"10.1074\/jbc.M115.670224_bib12","doi-asserted-by":"crossref","first-page":"719","DOI":"10.2217\/fon.14.272","article-title":"Efficacy and safety of ruxolitinib in the treatment of patients with myelofibrosis","volume":"11","author":"Arana Yi","year":"2015","journal-title":"Future Oncol"},{"key":"10.1074\/jbc.M115.670224_bib13","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1182\/blood-2014-04-566687","article-title":"JAK3 mutants transform hematopoietic cells through JAK1 activation, causing T-cell acute lymphoblastic leukemia in a mouse model","volume":"124","author":"Degryse","year":"2014","journal-title":"Blood"},{"key":"10.1074\/jbc.M115.670224_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0303-7207(00)00314-2","article-title":"Activation of the Jak\/Stat signal transduction pathway in GH-treated rat osteoblast-like cells in culture","volume":"168","author":"Gerland","year":"2000","journal-title":"Mol. Cell. Endocrinol"},{"key":"10.1074\/jbc.M115.670224_bib15","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.4049\/jimmunol.164.4.1814","article-title":"Cloning and characterization of IL-10-related T cell-derived inducible factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9","volume":"164","author":"Dumoutier","year":"2000","journal-title":"J. Immunol"},{"key":"10.1074\/jbc.M115.670224_bib16","doi-asserted-by":"crossref","first-page":"3924","DOI":"10.1182\/blood-2014-05-576652","article-title":"Cooperating JAK1 and JAK3 mutants increase resistance to JAK inhibitors","volume":"124","author":"Springuel","year":"2014","journal-title":"Blood"},{"key":"10.1074\/jbc.M115.670224_bib17","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1021\/jm101157q","article-title":"Identification of a potent Janus kinase 3 inhibitor with high selectivity within the Janus kinase family","volume":"54","author":"Thoma","year":"2011","journal-title":"J. Med. Chem"},{"key":"10.1074\/jbc.M115.670224_bib18","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.1038\/onc.2010.117","article-title":"Array-based genomic resequencing of human leukemia","volume":"29","author":"Yamashita","year":"2010","journal-title":"Oncogene"},{"key":"10.1074\/jbc.M115.670224_bib19","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.3109\/10428194.2011.574757","article-title":"Description of a novel Janus kinase 3 P132A mutation in acute megakaryoblastic leukemia and demonstration of previously reported Janus kinase 3 mutations in normal subjects","volume":"52","author":"Riera","year":"2011","journal-title":"Leukemia Lymphoma"},{"key":"10.1074\/jbc.M115.670224_bib20","doi-asserted-by":"crossref","first-page":"18962","DOI":"10.1073\/pnas.0509714102","article-title":"Expression of a homodimeric type I cytokine receptor is required for JAK2V617F-mediated transformation","volume":"102","author":"Lu","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.M115.670224_bib21","doi-asserted-by":"crossref","first-page":"6773","DOI":"10.1074\/jbc.M807531200","article-title":"Acute lymphoblastic leukemia-associated JAK1 mutants activate the Janus kinase\/STAT pathway via interleukin-9 receptor alpha homodimers","volume":"284","author":"Hornakova","year":"2009","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M115.670224_bib22","doi-asserted-by":"crossref","first-page":"33569","DOI":"10.1074\/jbc.M803125200","article-title":"Ligand-independent homomeric and heteromeric complexes between interleukin-2 or -9 receptor subunits and the \u03b3 chain","volume":"283","author":"Malka","year":"2008","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M115.670224_bib23","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1182\/blood-2007-07-102186","article-title":"The Jak2V617F oncogene associated with myeloproliferative diseases requires a functional FERM domain for transformation and for expression of the Myc and Pim proto-oncogenes","volume":"111","author":"Wernig","year":"2008","journal-title":"Blood"},{"key":"10.1074\/jbc.M115.670224_bib24","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/leu.2013.271","article-title":"Recurrent JAK1 and JAK3 somatic mutations in T-cell prolymphocytic leukemia","volume":"28","author":"Bellanger","year":"2014","journal-title":"Leukemia"},{"key":"10.1074\/jbc.M115.670224_bib25","doi-asserted-by":"crossref","first-page":"845","DOI":"10.3324\/haematol.2010.036350","article-title":"Oncogenic JAK1 and JAK2-activating mutations resistant to ATP-competitive inhibitors","volume":"96","author":"Hornakova","year":"2011","journal-title":"Haematologica"},{"key":"10.1074\/jbc.M115.670224_bib26","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1042\/BJ20100774","article-title":"Transforming JAK1 mutations exhibit differential signalling, FERM domain requirements and growth responses to interferon-\u03b3","volume":"432","author":"Gordon","year":"2010","journal-title":"Biochem. J"},{"key":"10.1074\/jbc.M115.670224_bib27","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1158\/1078-0432.CCR-11-2361","article-title":"EGFR exon 19 insertions: a new family of sensitizing EGFR mutations in lung adenocarcinoma","volume":"18","author":"He","year":"2012","journal-title":"Clin. Cancer Res"},{"key":"10.1074\/jbc.M115.670224_bib28","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.lungcan.2012.08.014","article-title":"Analysis of EGFR, KRAS and P53 mutations in lung cancer using cells in the curette lavage fluid obtained by bronchoscopy","volume":"78","author":"Yamaguchi","year":"2012","journal-title":"Lung Cancer"},{"key":"10.1074\/jbc.M115.670224_bib29","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3892\/ol.2013.1705","article-title":"Acquired resistance L747S mutation in an epidermal growth factor receptor-tyrosine kinase inhibitor-naive patient: A report of three cases","volume":"7","author":"Yamaguchi","year":"2014","journal-title":"Oncol. Lett"},{"key":"10.1074\/jbc.M115.670224_bib30","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0092-8674(02)00741-9","article-title":"The conformational plasticity of protein kinases","volume":"109","author":"Huse","year":"2002","journal-title":"Cell"},{"key":"10.1074\/jbc.M115.670224_bib31","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S1097-2765(01)00398-7","article-title":"Unexpected effects of FERM domain mutations on catalytic activity of Jak3: structural implication for Janus kinases","volume":"8","author":"Zhou","year":"2001","journal-title":"Mol. Cell"},{"key":"10.1074\/jbc.M115.670224_bib32","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.str.2010.10.010","article-title":"Structural snapshots of full-length Jak1, a transmembrane gp130\/IL-6\/IL-6Ralpha cytokine receptor complex, and the receptor-Jak1 holocomplex","volume":"19","author":"Lupardus","year":"2011","journal-title":"Structure"},{"key":"10.1074\/jbc.M115.670224_bib33","doi-asserted-by":"crossref","first-page":"8025","DOI":"10.1073\/pnas.1401180111","article-title":"Structure of the pseudokinase-kinase domains from protein kinase TYK2 reveals a mechanism for Janus kinase (JAK) autoinhibition","volume":"111","author":"Lupardus","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820412268?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820412268?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.M115.670224","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T11:09:09Z","timestamp":1641294549000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925820412268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":33,"journal-issue":{"issue":"48","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0021925820412268"],"URL":"https:\/\/doi.org\/10.1074\/jbc.m115.670224","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Distinct Acute Lymphoblastic Leukemia (ALL)-associated Janus Kinase 3 (JAK3) Mutants Exhibit Different Cytokine-Receptor Requirements and JAK Inhibitor Specificities","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/jbc.M115.670224","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}]}}